• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor.

作者信息

Tannock Ian F, Khan Qamar J, Fojo Tito

机构信息

Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada.

Department of Internal Medicine, University of Kansas Medical Center, Westwood, Kansas City, KS.

出版信息

J Clin Oncol. 2025 Aug;43(22):2456-2460. doi: 10.1200/JCO-24-02683. Epub 2025 Apr 14.

DOI:10.1200/JCO-24-02683
PMID:40228181
Abstract
摘要

相似文献

1
Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor.为何我们不建议乳腺癌女性接受CDK4/6抑制剂辅助治疗。
J Clin Oncol. 2025 Aug;43(22):2456-2460. doi: 10.1200/JCO-24-02683. Epub 2025 Apr 14.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.促黄体生成素释放激素激动剂用于绝经前女性早期乳腺癌的辅助治疗。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD004562. doi: 10.1002/14651858.CD004562.pub4.
4
Short-term and long-term effects of tibolone in postmenopausal women.替勃龙对绝经后女性的短期和长期影响。
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD008536. doi: 10.1002/14651858.CD008536.pub3.
5
"I Don't Understand Their Sense of Belonging": Exploring How Nonbinary Autistic Adults Experience Gender.“我不理解他们的归属感”：探索非二元性别的自闭症成年人如何体验性别。
Autism Adulthood. 2024 Dec 2;6(4):462-473. doi: 10.1089/aut.2023.0071. eCollection 2024 Dec.
6
Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.早期乳腺癌伴 1-3 个阳性淋巴结的女性术后放疗。
Cochrane Database Syst Rev. 2023 Jun 16;6(6):CD014463. doi: 10.1002/14651858.CD014463.pub2.
7
Treatments for breast abscesses in breastfeeding women.哺乳期妇女乳房脓肿的治疗方法。
Cochrane Database Syst Rev. 2015 Aug 17;2015(8):CD010490. doi: 10.1002/14651858.CD010490.pub2.
8
Exercise for women receiving adjuvant therapy for breast cancer.针对接受乳腺癌辅助治疗的女性的运动
Cochrane Database Syst Rev. 2016 Sep 21;9(9):CD005001. doi: 10.1002/14651858.CD005001.pub3.
9
CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis.CDK4/6 抑制剂作为激素受体阳性、HER2 阴性早期乳腺癌的辅助治疗：系统评价和荟萃分析。
ESMO Open. 2021 Apr;6(2):100091. doi: 10.1016/j.esmoop.2021.100091. Epub 2021 Mar 18.
10
First-Line Camizestrant for Emerging -Mutated Advanced Breast Cancer.针对新出现的特定突变晚期乳腺癌的一线用药卡米司他。
N Engl J Med. 2025 Jun 1. doi: 10.1056/NEJMoa2502929.

引用本文的文献

1
Axillary dissection should not be performed in breast cancer patients with limited nodal disease to determine abemaciclib candidacy.对于淋巴结疾病有限的乳腺癌患者，不应进行腋窝清扫以确定阿贝西利的适用性。
Gland Surg. 2025 Jul 31;14(7):1183-1186. doi: 10.21037/gs-2025-178. Epub 2025 Jul 28.
2
From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting- a number needed to treat perspective.从争议到明晰：重新审视CDK4/6抑制剂在辅助治疗中的作用——基于需治数的视角
J Cancer Res Clin Oncol. 2025 Jun 9;151(6):185. doi: 10.1007/s00432-025-06229-3.